Evolent Announces First Quarter 2026 Results
Evolent reported Q1 2026 revenue of $496.2 million, up 2.6% year-over-year, while net loss improved significantly to $(26.6) million from $(72.3) million in the prior year. Adjusted EBITDA declined to $22.1 million from $36.9 million a year earlier, with margin contracting to 4.4% from 7.6%.
Key figures
- Revenue
- 496246000
- Guidance
- FY26 revenue $2.4B-$2.6B, Adjusted EBITDA $110M-$140M
- Revenue Yoy
- 2.6%
- Adjusted ebitda
- 22067000
- Cash and equivalents
- 142000000
- Adjusted ebitda margin
- 4.4%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.